- Home
- KTTA vs SHPH Comparison
KTTA vs SHPH Comparison
Compare KTTA & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- SHPH
- Stock Information
- Founded
- KTTA 2020
- SHPH 2012
- Country
- KTTA United States
- SHPH United States
- Employees
- KTTA 8
- SHPH N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- KTTA Health Care
- SHPH Health Care
- Exchange
- KTTA Nasdaq
- SHPH Nasdaq
- Market Cap
- KTTA 3.4M
- SHPH 2.7M
- IPO Year
- KTTA 2021
- SHPH 2022
- Fundamental
- Price
- KTTA $2.64
- SHPH $0.63
- Analyst Decision
- KTTA
- SHPH
- Analyst Count
- KTTA 0
- SHPH 0
- Target Price
- KTTA N/A
- SHPH N/A
- AVG Volume (30 Days)
- KTTA 57.9K
- SHPH 77.5K
- Earning Date
- KTTA 11-13-2024
- SHPH 11-13-2024
- Dividend Yield
- KTTA N/A
- SHPH N/A
- EPS Growth
- KTTA N/A
- SHPH N/A
- EPS
- KTTA N/A
- SHPH N/A
- Revenue
- KTTA N/A
- SHPH N/A
- Revenue This Year
- KTTA N/A
- SHPH N/A
- Revenue Next Year
- KTTA N/A
- SHPH N/A
- P/E Ratio
- KTTA N/A
- SHPH N/A
- Revenue Growth
- KTTA N/A
- SHPH N/A
- 52 Week Low
- KTTA $2.57
- SHPH $0.62
- 52 Week High
- KTTA $9.40
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- KTTA 34.15
- SHPH 27.09
- Support Level
- KTTA $2.57
- SHPH $0.61
- Resistance Level
- KTTA $3.07
- SHPH $0.79
- Average True Range (ATR)
- KTTA 0.21
- SHPH 0.06
- MACD
- KTTA 0.01
- SHPH 0.00
- Stochastic Oscillator
- KTTA 14.49
- SHPH 12.15
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.